Cargando…

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis

IMPORTANCE: Patterns of clinical utilization and comparative effectiveness of anticoagulants for cancer-associated thrombosis (CAT) remain largely unexplored. OBJECTIVES: To assess patterns of and factors associated with anticoagulant use and to evaluate the comparative effectiveness of contemporary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riaz, Irbaz Bin, Fuentes, Harry, Deng, Yihong, Naqvi, Syed Arsalan Ahmed, Yao, Xiaoxi, Sangaralingham, Lindsey R., Houghton, Damon E., Padrnos, Leslie J., Shamoun, Fadi E., Wysokinski, Waldemar E., McBane, Robert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366701/ https://www.ncbi.nlm.nih.gov/pubmed/37486628 http://dx.doi.org/10.1001/jamanetworkopen.2023.25283

Ejemplares similares

Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021)

Accuracy and Prediction of D-Dimers for Pulmonary Embolism in Patients with COVID-19 Infection
por: Houghton, Damon E., et al.
Publicado: (2022)

A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
por: Joppa, Stephanie A., et al.
Publicado: (2018)

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
por: Kaufman, Adrienne, et al.
Publicado: (2021)

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015)

Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19
por: Pasha, Ahmed K., et al.
Publicado: (2021)

Deep Vein Thrombosis after COVID-19 Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2021)

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022)

Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Gaddh, Manila, et al.
Publicado: (2023)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
por: Cambron, Julia C., et al.
Publicado: (2020)

Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021)

Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
por: McBane, Robert D., et al.
Publicado: (2020)

Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes
por: Brunton, Nichole E., et al.
Publicado: (2021)

Arterial Thrombosis and Coronavirus Disease 2019
por: McBane, Robert D.
Publicado: (2021)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

The Evolving Treatment of Peripheral Arterial Disease through Guideline-Directed Recommendations
por: Morcos, Ramez, et al.
Publicado: (2018)

Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
por: O'Callaghan, Marissa, et al.
Publicado: (2018)

Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization
por: Chaudhary, Rahul, et al.
Publicado: (2020)

In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study
por: van Zyl, Martin, et al.
Publicado: (2020)

P1645: IMPACT OF VON WILLEBRAND FACTOR AND ADAMTS13 ON CARDIOVASCULAR COMPLICATIONS AND BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND NORMAL SINUS RHYTHM CONTROLS: 10 YEARS FOLLOW UP.
por: Wysokinski, Waldemar, et al.
Publicado: (2023)

Pulmonary venous thrombosis in a patient with COVID-19 infection
por: Pasha, Ahmed K., et al.
Publicado: (2021)

Discordant Values in Lower Extremity Physiologic Studies Predict Increased Cardiovascular Risk
por: Firth, Christine, et al.
Publicado: (2020)

Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management
por: Shamoun, Fadi, et al.
Publicado: (2015)

May‐Thurner syndrome and thrombosis: A systematic review of antithrombotic use after endovascular stent placement
por: J. Padrnos, Leslie, et al.
Publicado: (2018)

Guidance for the management of venous thrombosis in unusual sites
por: Ageno, Walter, et al.
Publicado: (2016)

Anticoagulation in Behçet related intrathoracic vasculitis
por: Nokes, Brandon, et al.
Publicado: (2018)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
por: Wysokinski, Waldemar E., et al.
Publicado: (2020)

P1657: CANCER-ASSOCIATED NON-BACTERIAL THROMBOTIC ENDOCARDITIS AFFECTING RIGHT HEART VALVES AS POTENTIAL CAUSE OF PULMONARY EMBOLISM
por: Wysokinska, Ewa, et al.
Publicado: (2023)

Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
por: Mookadam, Martina, et al.
Publicado: (2015)

Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients
por: Firth, Christine, et al.
Publicado: (2023)

Evaluation of Changing Vena Cava Filter Use and Inpatient Hospital Mortality from 2016-2019: A Single-Institution Quality Improvement Project
por: Augustine, Matthew R., et al.
Publicado: (2021)

Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage: A Systematic Review and Meta-analysis
por: Chaudhary, Rahul, et al.
Publicado: (2022)

Thromboembolism and the Pandemic
por: McBane, Robert D.
Publicado: (2020)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
por: Tan, Nicholas Y., et al.
Publicado: (2021)

Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Anticoagulant Therapy in Thrombosis
por: Jorpes, J. Erik
Publicado: (1946)

Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)

Thrombosis and anticoagulation in COVID-19
por: Ramos, Roberta Pulcheri, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3vo1em1uajr61pvgak0rom7khv